NCT07816692Recruiting
iDose TR Administration in an Office-Based Surgery Setting
Real-World Evidence Observational Study to Evaluate the Safety of iDose® TR (Travoprost Intracameral Implant) 75 µg in an Office-Based Surgery Setting
Source: ClinicalTrials.gov · Last updated 30 Sept 2026
Brief summary (registry, in English)
Clinical in-use observational trial to evaluate the administration of iDose TR (travoprost intracameral implant) in an office-based surgery setting.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 30 (estimated)
- First submitted
- 8 Sept 2026
- Start date
- 13 May 2026
- Primary completion date
- Mar 2027
- Lead sponsor
- Glaukos Corporation
- Diseases
- Glaucoma, High blood pressure
- NCT number
- NCT07816692
What you commit to
- Study type: Observational
- Planned participants: 30
- From 13 May 2026 to the primary completion date, Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior administration of iDose TR or administration of an investigational intracameral implant in the study eye
- Recent ocular surgery
Other illness
- Active ocular infection or inflammation
- History of hypersensitivity to travoprost or implant components
- Uncontrolled systemic disease
- Any condition preventing safe implantation
Who the study is looking for
- Diagnosis of Open angle glaucoma (OAG) or ocular hypertension (OHT)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| - Coordinator of this site? Confirm its status | Austin | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.